HSR24-152: Patient-Reported Outcome (PRO) Data in Oncology NDAs Approved by the FDA (2018–2021): A Review of Criticism and Concerns in Comments From Regulators

Authors: Erin Comerford, Lindsey Norcross, Medha Sasane, Ying Zheng, Ari Gnanasakthy

Published: 2024-04-05

DOI: 10.6004/jnccn.2023.7146

Source: Full article

---

Abstract

No abstract found.